We recall, as noted in the Introduction, that for wild type mouse, both CD4+ and CD8+ T cells produce IL-10 and IFN-[9]–[11] and we assume that IL-10 secreted by CD4+ T cells has the same tumor rejection quality as the IL-10 secreted by CD8+ T cells. This evidence concerns the gene IL10 and neoplasm.